China Medical University
Taichung, 406, Taiwan
NCT Number: NCT05600478
This descriptive-comparative study has explored and presented an overview of the extent of PT practice in the ICU in JP, PH, and TW. Specifically, the socio-demographic and ICU-related profiles of physical therapists (PTs) in Japan (JP), Philippines (PH), and Taiwan (TW) were presented, with the inclusion of the common PT interventions and challenges encountered in delivering PT services in the ICU in the said countries.
Included in the socio-demographic variables are the respondents' sex, age, highest educational attainment, PT work experience, and hospital affiliation. As to the ICU-related variables, it includes the respondents' ICU work experience, the types of ICU where respondents primarily work, the hiring department they belong to, the status of ICU posting, the duration of ICU posting, the daily ICU stay of the respondents, their engagement in on-call ICU PT services, the usual source of ICU patient referral, the number of daily ICU patients, the ratio of PT to ICU patients, and the level of participation in ICU-related PT training. Furthermore, different interventions that are commonly implemented and challenges that are commonly encountered in ICU PT service delivery in Japan, Philippines, and Taiwan were also investigated.
Looking for future studies?
Notify MeAll sexes
Observational
Taichung, 406, Taiwan
Physical therapy (PT) is proven beneficial among critically ill patients. However, there is an extent to the practice of PT in the intensive care unit (ICU) which differs between countries. With this, the extent of PT practice in the ICU in three Asian countries, namely Japan (JP), Philippines (PH), and Taiwan (TW), was determined and compared by specifically determining the socio-demographic and ICU-related profile of physical therapists (PTs) who have worked in the ICU.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: November 6, 2021 to February 18, 2022
Asked in the form of MCQ
Time frame: November 6 2021, to February 18, 2022
PhD, Master, diploma
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (by age range)
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (with sub-classification: level, ownership, teaching affiliation)
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (in range)
Time frame: November 6 2021, to February 18, 2022
Multiple answer question
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (by time range)
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (by time range)
Time frame: November 6 2021, to February 18, 2022
Asked in the form of a dichotomous question
Time frame: November 6 2021, to February 18, 2022
Asked via short answer question
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ (by range)
Time frame: November 6 2021, to February 18, 2022
Asked in the form of MCQ
Time frame: November 6 2021, to February 18, 2022
Asked in the form of dichotomus, MCQ, and multiple answer question
Time frame: November 6 2021, to February 18, 2022
Multiple answer question
Time frame: November 6 2021, to February 18, 2022
Multiple answer question
China Medical University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05559970
ICU, Lung Diseases
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT07330986
Aspergillosis, Bacterial Infections and Mycoses
Nanjing, China
View Trial DetailsNCT06969196
Behavior, Communication
Chicago, Illinois, United States
View Trial DetailsNCT07244731
COVID - 19, COVID-19
Ankara, Turkey (Türkiye)
View Trial Details